Navigation Links
Results From Phase II Trial in Critical Care Medicine Showed Eritoran Tetrasodium (E5564) To Be Well Tolerated in Patients with Severe Sepsis
Date:12/22/2009

WOODCLIFF LAKE, N.J., Dec. 22 /PRNewswire/ -- The investigational compound, eritoran tetrasodium ("eritoran," also known as E5564) appeared to be well tolerated in patients with severe sepsis in a Phase II trial published in the January issue of Critical Care Medicine, the official journal of the Society of Critical Care Medicine, the largest multiprofessional organization dedicated to ensuring excellence and consistency in the practice of critical care.

The trial evaluated two doses of eritoran, low-dose (45mg given every 12 hours for six days) and high-dose (105mg given every 12 hours for six days), along with a placebo group. Additionally, the trial, although not powered for statistical significance, evaluated the efficacy (reduction in 28-day all-cause mortality) of eritoran versus placebo.

"Currently, limited treatment options exist for severe sepsis. In this Phase II study, eritoran was well tolerated, and the adverse events were not surprising, given the significant co-morbidities commonly seen in patients with severe sepsis," said lead investigator Mark Tidswell, MD, Director, ICU Research, Baystate Medical Center, Adult Critical Care Division, in Springfield, Mass. "Although this Phase II trial was not sized to demonstrate a reduction in mortality and the observed 26.6% mortality rate for high-dose eritoran versus 33.3% for placebo (p=0.34) was not statistically significant, the data warrant further investigation of eritoran."

About the Phase II Trial

This trial of eritoran tetrasodium (E5564) was a Phase II, randomized, double-blind, placebo-controlled, multi-center, ascending-dose trial evaluating the safety and efficacy of eritoran in patients with severe sepsis. The trial, conducted in intensive care units (ICUs) in the United States and Canada, involved 300 patients randomized to three groups: 96 received placebo, 103 received eritoran low-dose (45mg given every 12 hours for si
'/>"/>

SOURCE Eisai
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders
2. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
3. American Imaging Managements New Specialty Drug Program Delivers Immediate Results
4. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
5. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
6. Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010
7. Robbins & Myers To Release First Quarter Fiscal 2010 Financial Results
8. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
9. AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial
10. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
11. Neogen Corporation Announces 2nd Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Net Medical Xpress Solutions, Inc., (OTC QB: ... the company has signed a letter of intent to ... Huntsville, AL . MedTel Solutions is ... and recruitment of telemedicine physicians. Consideration for the acquisition ... which is expected by June 30, 2013. ...
(Date:5/23/2013)... , May 23, 2013  Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation (NASDAQ: ... Investigational New Drug Application (IND) to evaluate OMS824 ... U.S. Food and Drug Administration (FDA). OMS824 selectively ... areas of the brain linked to a wide ... disease and schizophrenia. OMS824 has shown promising results ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Cardinal Health Selects Datameer for Healthcare Data Discovery 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4
(Date:5/23/2013)... News) -- A modified version of the polio ... preliminary research suggests. Scientists at Duke Cancer ... PVSRIPO, uses an engineered form of the virus ... cancer cells. The therapy shows promise in the ... brain tumor, they said. "These early results ...
(Date:5/23/2013)... (May 23, 2013)Don,t doubt it when a woman harried ... remembering things. A new study published online in ... Society (NAMS), helps confirm with objective tests that what ... In the past, some studies showed that hot flashes ... studies showed that, even though there was a relationship ...
(Date:5/23/2013)... PA (PRWEB) May 23, 2013 ... Teaching Site, offering a comprehensive babysitting training course for ... program was developed by Indianapolis pediatrician Dr. Patricia Keener ... the care of an adult sitter who didn’t know ... well-rounded youth development program with a medical basis that ...
(Date:5/23/2013)... anti-cancer drug about to be tested in a clinical ... possible treatment for Alzheimer,s disease has failed to work ... Alzheimer,s patients, according to results of a study by ... professor of neuroscience affiliated with the Evelyn F. and ... Florida, emphasized the importance of verifying promising research results ...
(Date:5/23/2013)... The Rottenstein Law Group LLP, a New York-based nationwide ... Information Center at http://www.rotlaw.com/tylenol , dedicated to issues ... considering filing lawsuits. , The painkiller Tylenol (acetaminophen) ... according to a 2009 report from the U.S. Food ... FDA warned consumers against using more than the recommended ...
Breaking Medicine News(10 mins):Health News:Modified Polio Virus May Help Fight Brain Tumors, Study Suggests 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2
... 15 Want beautifully clear, acne-free skin, naturally? Skip ... nature with Burt,s Bees(®) Natural Acne Solutions(TM) products. , ... http://multivu.prnewswire.com/mnr/burtsbees/40454/ , (Photo: ... first and only truly natural* acne line clinically ...
... In support of National Latino AIDS Awareness Day, Tibotec ... commitment to raising awareness of HIV/AIDS issues in the ... GRACE (Gender, Race And Clinical Experience) study, the largest ... treated with HIV medications (treatment-experienced) to compare gender differences ...
... to nature , THURSDAY, Oct. 15 (HealthDay News) -- The closer ... For instance, people who live within 1 kilometer of a park ... , The findings put concrete numbers on a concept that ... nice to see that it shows that, that the closer humans ...
... Oxford UK, 15 October 2009 Elsevier, a ... products and services announced today the launch of ... Spatio-temporal Epidemiology ( http://www.elsevier.com/locate/sste ). The first ... be a primary forum for academics and scholars ...
... Researchers at St. Michael,s Hospital have developed the ... more quickly and reliably diagnose acute heart failure (AHF) ... Journal of the American College of Cardiology , ... greater accuracy. "In Canada, more than 100,000 people ...
... The NFL and National Dairy Council (NDC) today launch Fuel ... childhood obesity by giving youth a voice in changing the ... 36 million youth in 60,000 elementary, middle and high schools ... children and teens to take charge of their health and ...
Cached Medicine News:Health News:Video: Introducing Natural Acne Solutions(TM) By Burt's Bees(R) 2Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 2Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 3Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 4Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 5Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 6Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 7Health News:Green Spaces Boost the Body and the Mind 2Health News:Green Spaces Boost the Body and the Mind 3Health News:Elsevier announces launch of Spatial and Spatio-temporal Epidemiology 2Health News:New mathematical model more accurately diagnoses acute heart failure in emergency rooms 2Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 2Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 3Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 4Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 5
... Ultra Strep A Test is a color ... DLT uses antibody labeled color particles coated ... device. DLT allows greater sensitivity than the ... In the test procedure, a throat swab ...
... Fertell test is an easy to use, one ... reserve by means of determining the amount of ... sample. The test is performed two days after ... menstrual cycle) and is similar in design and ...
... The Cholestech GDX System delivers an unmatched combination ... ideal solution for assessing and monitoring a patient's ... demo, click here ., ,The CLIA-waived Cholestech ... A1C results in less than 5 minutes. The ...
... The Cholestech LDX System, using patented, ... plus glucose and ALT in only 5 ... new ALT test, you can get immediate ... measurement capabilities is not the only advantage ...
Medicine Products: